A 3 Years Naturalistic Cohort Survey Of Virtue® Male Sling System For Male Stress Urinary Incontinence
← catalyst calendarSponsored by Coloplast A/S (industry) · COLO-B.CO — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
130estimated
Sites
13
Countries
France, Italy
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2017-06-29 | actual | When the study began enrolling |
| Primary completion | Dec 2024 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2019-09-23 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2023-02-21 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Urinary Incontinence, Stress
Intervention
- Device: Virtue male sling
Primary outcomes
what the primary-completion date above is the date OFPatient Global Impression of Improvement (PGI-I)
measured 12 months
Adverse events
measured 12 months
Permalink · COLO-B.CO's whole pipeline · Catalyst calendar · Every registered study · What changed